|The purpose of the Shionogi Group’s corporate activities is, as expressed in the opening of “The Company Policy of Shionogi”, to “supply the best possible medicine to protect the health and wellbeing of the patients we serve.” This eternal and unwavering corporate philosophy is our foundation which supports us and what we should achieve globally. To achieve and live by the Company Policy, we have formulated “Shionogi Group Code of Conduct”. Through activities based on “The Company Policy of Shionogi” and “Shionogi Group Code of Conduct”, Shionogi will continue to contribute to patients, physicians and other healthcare providers, shareholders and investors, and furthermore to society as a whole.
Shionogi believes that disclosure of appropriate information from antimicrobial surveillance programs contributes to advancing scientific progress and improving public health, and ultimately helps patients and healthcare providers make informed clinical decisions.
|How we share on the AMR Register
|To obtain Shionogi’s AMR surveillance data for analysis, researchers should use the AMR Register platform to submit a request. The anonymized data will then be made available to the researcher to download. Data for ongoing surveillance programs will be updated annually.
|Programs listed for sharing
|Shionogi AMR surveillance data available on the AMR Register:
|What information will be provided
|Where available, the following data and information is provided for each dataset:
🗹 Raw dataset. This is the dataset containing the de-identified isolate level data collected during the study. The dataset can be downloaded.
🗹 Program description. Information about how the data were collected are provided on the program pages.
🗹 Links to Publications. Links to journal publications based on the data collected are provided on the program pages.
|Questions or enquiries
|Please send any questions or enquiries to firstname.lastname@example.org
|Shionogi Register or Website
|Shionogi’s AMR commitment